(redirected from Uroflowmetry)
Also found in: Medical.
UFRUnité de Formation et de Recherche (French universities research and teaching unit)
UFRUniversité François-Rabelais (French university)
UFRUltimate Forward Rate (financial valuation)
UFRUltra Fast Rendering (printing)
UFRUltrafiltration Rate (kidney dialysis)
UFRUpon Further Review
UFRUltra Fast Rendering
UFRUrea Formaldehyde Resin
UFRUnion of Republican Forces (Guinea)
UFRUse of Fund Resources (International Monetary Fund)
UFRUnfunded Requirements
UFRUnion of Forces of Resistance (Chad)
UFRUnbiased Forward Rate (international finance, exchange rates)
UFRUnfinanced Requirement
UFRUnder-Frequency Relay
UFRUnion Française des Retraités (French: French Union of Retirees)
UFRUnmeasured Flow Reducer (water supply device)
UFRUnit Failure Rate
UFRUpper Fuser Roller (copier component)
UFRUpper Fuser Roller
UFRUmbilicals, Flowlines & Risers (engineering, surface facilities)
UFRUser Feedback Report
UFRUltimate Free Runners
UFRUltra Fast Ramp (semiconductor manufacturing)
UFRUniform Financial Statement and Independent Auditor's Report
References in periodicals archive ?
Uroflowmetry was measured by voiding into an uroflowmeter--Urodyn 1000 DANTEC Type 22 G02, which used an uroflow transducer from a rotating drum.
Conclusion: The standing voiding position in healthy people influenced uroflowmetry findings, and was associated with higher flow rates.
The patient was followed up by ISC (after spontaneous voiding four times daily) and uroflowmetry intermittently.
The non-catheterized NB patients (n=7) and children from the reference group underwent uroflowmetry (3 times to precise the outcomes), and averaged outcome was calculated.
The diagnosis of BOO was based on the presence of significant lower urinary tract syndrome (LUTS) and obstructed uroflowmetry rates.
Assessments included detailed medical history, digital rectal examination, filling of International Prostate Symptom Score (IPSS) to assess LUTS, urine analysis, uroflowmetry assessment, kidney and bladder ultrasound and blood laboratory analysis including basic biochemical and haematological parameters, PSA and plasma selenium.
For these men, the symptom scores for the month before catheterisation were obtained; uroflowmetry could not be undertaken.
Urinalysis, uroflowmetry, and a bladder diary from the patient are also quick and useful tools.
During the health examination on the first day, after 3-months, and on the last day of the trial the following parameters were routinely assessed: (i) detailed medical history; (ii) assessment of all concurrent medical drugs and therapies; (iii) digital rectal examination; (iv) dietary habits; (v) filling of International Prostate Symptom Score (1PSS); (vi) urine analysis; (vii) uroflowmetry with postvoidal residual urine (RV); (viii) kidney and bladder ultrasound; and (ix) a blood laboratory analysis.
Apart from a full history and clinical examination, evaluation included the international prostate symptom score (IPSS), uroflowmetry and ultrasound measurement of the post-void residual.
The patients had their prostate volume determined using transabdominal ultrasound; then free uroflowmetry was performed in a standing position (with the minimum voided volume of 150 ml), determining the maximum urinary flow rate ([Q.